Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date: June 26, 2026
Context: The filing discloses the company's participation in investor and analyst meetings in June 2026 and furnishes the associated presentation materials as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of investor presentation materials and does not contain a financial statement or earnings release.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to satisfy Regulation FD disclosure requirements regarding the distribution of presentation materials.
Guidance, Outlook, and Risks
Management Commentary: The company is engaging with investors and analysts using materials dated June 26, 2026.
Legal Disclaimer: The presentation materials and the information in Item 7.01 are not deemed "filed" under Section 18 of the Exchange Act and are not subject to the liabilities of that section, nor are they incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Presentation dated June 26, 2026) for specific financial data and strategic updates.
- Verify the content on the company's Investor Relations website at https://investors.inspiresleep.com.
- Note that the presentation materials are not legally "filed" for liability purposes under Section 18 of the Exchange Act.